Regeneron pumping a further $350m into ex-Dell Irish biologics plant
A $350m investment will make Regeneron’s Limerick plant “the largest-scale bulk biologics production facility in Ireland,” the firm says, and add a further 200 jobs.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs